Coast Medical Innovations, LLC — SEC Form D Filing
Coast Medical Innovations, LLC filed an SEC Form D on October 8, 2026, reporting $550K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 8, 2026
- Amount reported
- $550K
- Round stage
- Seed
- Industry
- Medical Devices
- Website
- https://www.coastcmi.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: FLORIDA
Problem
The fundamental design of drainage catheters has remained largely unchanged for decades, leading to stubbornly high failure rates, routine occlusion and dislodgement, and increased costs for hospitals and patients. Up to 30% of placed catheters suffer dislodgement, and occlusion rates for conventional catheters range from 14% to 40%.
Solution
Coast Medical Innovations is developing the Coriolis Catheter, a patent-pending device that reimagines drainage catheters with a breakthrough design. This novel device directly addresses existing failures by dramatically reducing dislodgement, eliminating occlusion, and providing continuous output monitoring without requiring changes to existing clinical workflows.
Why now
Despite being a large and growing market, the drainage catheter market has been underserved by innovation, with existing designs failing frequently. There is a strong demand from hospitals for cost-saving solutions that improve patient outcomes and clinical efficiency, which the Coriolis Catheter is engineered to provide.
Verdict
This cleared because the team articulated a direct solution to a high-incidence, measurable clinical failure, not because the underlying market was undergoing a fundamental shift. Investors were implicitly betting on clinical validation accelerating quickly enough to disrupt entrenched, but under-innovated, incumbent product lines. The upside was constrained by the long regulatory pathways and the highly conservative procurement cycles typical for medical devices, prioritizing incremental clinical improvements over radical market capture.
Source: SEC EDGAR Form D filing